SCHEME 1
F a cile Syn th esis of 4-Alk yl (a n d
Ar yl)-2-a r yl-6-d ia zo-4H-
th ien o[3,2-b]p yr id in e-5,7-d ion es
Dong J oon Lee and Kyongtae Kim*
School of Chemistry and Molecular Engineering,
Seoul National University, Seoul 151-742, Korea
SCHEME 2
kkim@plaza.snu.ac.kr
Received February 10, 2004
Ab st r a ct : Treatment of 3-{3-alkyl (and aryl)amino-5-
arylthieno-2-yl}-2-diazo-3-oxopropanoates 8 with TMSOTf
(3 equiv) in the presence of Et3N (6 equiv) in CH2Cl2 for 1 h
at room temperature afforded 4-alkyl (and aryl)-2-aryl-6-
diazo-4H-thieno[3,2-b]pyridine-5,7-diones 14 in excellent
yields. On heating of 14 in the presence of a catalytic amount
of Rh2(CF3CF2CF2CO2)4 in PhH for 4-10 h at reflux,
corresponding ring contraction products, 4-alkyl (and aryl)-
5,6-dihydro-4H-thieno[3,2-b]pyrrol-5-ones 16, were produced
in good to excellent yields.
SCHEME 3
2-Diazocyclohexane-1,3-dione and diazoquinolinedione
derivatives are an important class of organic compounds.
The former are utilized as intermediates for the synthesis
of â-substituted R-chloroenones that are used as valuable
intermediates in the synthesis of R-carbon-substituted
enones1 and biologically active natural products.2 For
example, treatment of 2-diazocyclohexane-1,3-dione 1
with acetyl chloride at room temperature for 3 h gave
Taber’s method.7 Quinolinediones, precursors of 3, are
either commercially available or can be prepared by
cyclizing the corresponding anthranilic acids with acetic
anhydride in acetic acid.8 Surprisingly, 6-diazo-4H-thieno-
[3,2-b]pyridine-5,7-diones or 6-diazo-4H-furo[3,2-b]pyri-
dine-5,7-diones, analogous to compounds 3, have not been
reported.
A search of the literature revealed that there is one
report9 describing the synthesis of 7-hydroxy-4H-thieno-
[3,2-b]pyridine-5-one 7 by hydrolysis, followed by decar-
boxylation of 6-ethoxycarbonyl-7-hydroxy-4H- thieno[3,2-
b]pyridin-5-one 6, prepared starting from ethyl 3-amino-
thiophene-2-carboxylate and diethyl malonate in two
steps (Scheme 3). However, the method is of limited
usefulness due to difficulty with accessing the introduc-
tion of aryl groups at the nitrogen atom of the pyridine
moiety as well as the inaccessibility of the starting
materials, i.e., 3-aminothiophene-2-carboxylate with di-
verse substituents at the 5-position.
3-acetoxy-2-chlorocyclohex-2-enone
(Scheme 1).
2
in 81% yield3
The latter are useful for the synthesis of biologically
active compounds. For example, N-alkyldiazoquinolinedi-
one 3 undergoes cyclization with vinyl acetate in the
presence of Rh2(piv)4 catalyst in acidic EtOH to give
2-acetoxy-9-alkyl-2,3-dihydrofuro[2,3-b]quinoline-4-one 44
(Scheme 2), which can be further converted to naturally
occurring alkaloids.
In addition, rhodium(II)-catalyzed reactions of 3 in
refluxing CH3CN gave oxindoles 55,6 (Scheme 2), which
are valuable synthetic intermediates of natural and
pharmaceutical reagents. Compounds 1 and 3 were
readily prepared by the diazo transfer reactions of the
corresponding 1,3-diones with mesyl azide according to
Accordingly, it may be worthwhile to explore the
synthetic method of the foregoing unexplored fused
pyridine-5,7-diones, whose diazo compounds would be
expected to comprise a promising starting material for
the synthesis of novel bioactive compounds.
* Phone: 82 2880 6636. Fax: 82 2874 8858.
(1) Lee, Y. R.; J ung, Y. S. J . Chem. Soc., Chem. Commun. 1998,
2621-2622 and references cited therein.
(2) (a) J ohnson, C. R.; Braun, M. P. J . Am. Chem. Soc. 1993, 115,
11014-11015. (b) J ohnson, C. R.; Harikrishnan; Golebiowski, A.
Tetrahedron Lett. 1994, 35, 7735-7738.
Recently, we reported a synthesis of a mixture of 5,6-
dihydro-4H-thieno[3,2-b]pyrrol-5-one and the correspond-
(3) (a) Alonso, M. E.; Chitty A. W. Tetrahedron Lett. 1981, 22, 4181-
4184. (b) Alonso, M. E.; Garcia, M. C.; Chitty, A. W. J . Org. Chem.
1985, 50, 3445-3449.
(4) Pirrung, M. C.; Blume, F. J . Org. Chem. 1999, 64, 3642-3649.
(5) Lee, Y. R.; J ung, Y. S.; Kim, B. S. Tetrahedron Lett. 1999, 40,
8219-8221.
(7) Taber, D. F.; Ruckle, R. E., J r.; Hennessy, M. J . Org. Chem. 1986,
51, 4077-4078.
(8) (a) Buckle, D. R.; Cantello, B. C. C.; Smith, H.; Spice, B. A. J .
Med. Chem. 1975, 18, 726-732. (b) Lutz, R. E.; Codington, J . F.;
Rowlett, R. J .; Deint, A. J .; Bailey, P. S. J . Am. Chem. Soc. 1946, 68,
1810-1812.
(6) (a) Lakahmaiah, G.; Kawabata, T.; Shang, M.; Fuji, K. J . Org.
Chem. 1999, 64, 1699-1704. (b) van Henegouwen, W. G. B.; Hiemstra,
H. J . Org. Chem. 1997, 62, 8862-8867. (c) Miah, S.; Moody, C. J .;
Richards, I. C.; Slawin, A. M. Z. J . Chem. Soc., Perkin Trans. 1. 1997,
2405-2412.
(9) Baker, J . M.; Huddleston, P. R.; Chadwick, N.; Keenan, G. J . J .
Chem. Res., Synop. 1980, 6-7.
10.1021/jo049769a CCC: $27.50 © 2004 American Chemical Society
Published on Web 06/17/2004
J . Org. Chem. 2004, 69, 4867-4869
4867